ChitogenX Inc.
CHGX
Rankning i aktier
#39852
ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and... ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.
Aktiekurs
$0.00365786
Senast synkroniserad: 2025-07-07
Marknadsvärde
$293.82K
Förändring (1 dag)
-0.43%
Förändring (1 år)
-28.28%
Land
CA
Handel ChitogenX Inc. (CHGX)
Kategori
Healthcare
Aktiekurshistorik för ChitogenX Inc. (CHGX)
Högsta slutkurs: $0.01 den 2026-10-01
Lägsta slutkurs: $0.46 den 2020-10-01
Lägsta slutkurs: $0.46 den 2020-10-01
Aktiekurshistorik för ChitogenX Inc. från 2020 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -53.93% |
| 2024 | -85.54% |
| 2023 | -64.19% |
| 2022 | -43.64% |
| 2021 | -43.08% |
| 2020 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $535.96 | 25.68% |
US
|
|
| $186.23 | 593.59% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $892.29 | 9.59% |
NL
|
